Althea Group Holdings Ltd - Asset Resilience Ratio
Althea Group Holdings Ltd (AGH) has an Asset Resilience Ratio of 18.69% as of June 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AGH net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2020)
This chart shows how Althea Group Holdings Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Althea Group Holdings Ltd's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Althea Group Holdings Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Althea Group Holdings Ltd to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$10.14 Million | 18.69% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$10.14 Million | 18.69% |
Asset Resilience Insights
- Good Liquidity Position: Althea Group Holdings Ltd maintains a healthy 18.69% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Althea Group Holdings Ltd Industry Peers by Asset Resilience Ratio
Compare Althea Group Holdings Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
IPSEN SA SP.ADR 1/4/ EO 1
F:I7G0 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728 |
Drug Manufacturers - Specialty & Generic | 9.66% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
Annual Asset Resilience Ratio for Althea Group Holdings Ltd (2018–2020)
The table below shows the annual Asset Resilience Ratio data for Althea Group Holdings Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-06-30 | 19.36% | AU$10.14 Million ≈ $7.18 Million |
AU$52.38 Million ≈ $37.06 Million |
-35.34pp |
| 2019-06-30 | 54.70% | AU$10.00 Million ≈ $7.08 Million |
AU$18.28 Million ≈ $12.93 Million |
+48.64pp |
| 2018-06-30 | 6.06% | AU$200.00K ≈ $141.51K |
AU$3.30 Million ≈ $2.33 Million |
-- |
About Althea Group Holdings Ltd
Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercia… Read more